These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26220091)

  • 1. Exploration of individuality in drug metabolism by high-throughput metabolomics: The fast line for personalized medicine.
    Trifonova O; Knight RA; Lisitsa A; Melino G; Antonov AV
    Drug Discov Today; 2016 Jan; 21(1):103-110. PubMed ID: 26220091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomics in pharmacology - a delve into the novel field of pharmacometabolomics.
    Mussap M; Loddo C; Fanni C; Fanos V
    Expert Rev Clin Pharmacol; 2020 Feb; 13(2):115-134. PubMed ID: 31958027
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacometabonomics: data processing and statistical analysis.
    Fu J; Zhang Y; Liu J; Lian X; Tang J; Zhu F
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33866355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individualization of treatments with drugs metabolized by CES1: combining genetics and metabolomics.
    Rasmussen HB; Bjerre D; Linnet K; Jürgens G; Dalhoff K; Stefansson H; Hankemeier T; Kaddurah-Daouk R; Taboureau O; Brunak S; Houmann T; Jeppesen P; Pagsberg AK; Plessen K; Dyrborg J; Hansen PR; Hansen PE; Hughes T; Werge T;
    Pharmacogenomics; 2015; 16(6):649-65. PubMed ID: 25896426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Networking As a Drug Discovery, Drug Metabolism, and Precision Medicine Strategy.
    Quinn RA; Nothias LF; Vining O; Meehan M; Esquenazi E; Dorrestein PC
    Trends Pharmacol Sci; 2017 Feb; 38(2):143-154. PubMed ID: 27842887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualized metabolomics: opportunities and challenges.
    Misra B
    Clin Chem Lab Med; 2020 Jun; 58(6):939-947. PubMed ID: 30951498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration of variations in proteome and metabolome for predictive diagnostics and personalized treatment algorithms: Innovative approach and examples for potential clinical application.
    Zhan X; Long Y; Lu M
    J Proteomics; 2018 Sep; 188():30-40. PubMed ID: 28851587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized Metabolomics.
    Marciano DP; Snyder MP
    Methods Mol Biol; 2019; 1978():447-456. PubMed ID: 31119679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomics through the lens of precision cardiovascular medicine.
    Lam SM; Wang Y; Li B; Du J; Shui G
    J Genet Genomics; 2017 Mar; 44(3):127-138. PubMed ID: 28325553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomics and Personalized Medicine.
    Koen N; Du Preez I; Loots du T
    Adv Protein Chem Struct Biol; 2016; 102():53-78. PubMed ID: 26827602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomics: moving to the clinic.
    Nordström A; Lewensohn R
    J Neuroimmune Pharmacol; 2010 Mar; 5(1):4-17. PubMed ID: 19399626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translational and emerging clinical applications of metabolomics in cardiovascular disease diagnosis and treatment.
    Dona AC; Coffey S; Figtree G
    Eur J Prev Cardiol; 2016 Oct; 23(15):1578-89. PubMed ID: 27103630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomics - A wide-open door to personalized treatment in chronic heart failure?
    Marcinkiewicz-Siemion M; Ciborowski M; Kretowski A; Musial WJ; Kaminski KA
    Int J Cardiol; 2016 Sep; 219():156-63. PubMed ID: 27323342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR-based pharmacometabonomics: A new paradigm for personalised or precision medicine.
    Everett JR
    Prog Nucl Magn Reson Spectrosc; 2017 Nov; 102-103():1-14. PubMed ID: 29157489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging Applications of Metabolomics in Clinical Pharmacology.
    Pang H; Jia W; Hu Z
    Clin Pharmacol Ther; 2019 Sep; 106(3):544-556. PubMed ID: 31173340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomics toward personalized medicine.
    Jacob M; Lopata AL; Dasouki M; Abdel Rahman AM
    Mass Spectrom Rev; 2019 May; 38(3):221-238. PubMed ID: 29073341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomics: Applications and Promise in Mycobacterial Disease.
    Mirsaeidi M; Banoei MM; Winston BW; Schraufnagel DE
    Ann Am Thorac Soc; 2015 Sep; 12(9):1278-87. PubMed ID: 26196272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel strategies for clinical investigation and biomarker discovery: a guide to applied metabolomics.
    Carneiro G; Radcenco AL; Evaristo J; Monnerat G
    Horm Mol Biol Clin Investig; 2019 Jan; 38(3):. PubMed ID: 30653466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in metabolomics-based disease molecular classification: an analytical perspective.
    Gao Y; Liu Q; Xu F
    Bioanalysis; 2017 May; 9(10):771-773. PubMed ID: 28520467
    [No Abstract]   [Full Text] [Related]  

  • 20. Individual Biomarkers Using Molecular Personalized Medicine Approaches.
    Zenner HP
    ORL J Otorhinolaryngol Relat Spec; 2017; 79(1-2):7-13. PubMed ID: 28231575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.